ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Cost of revenue

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndCost of revenue (Million USD)YoY (%)
Dec 31, 202519,319+3.28%
Dec 31, 202418,706+4.07%
Dec 31, 202317,975-6.10%
Dec 31, 202219,142+3.26%
Dec 31, 202118,537+23.56%
Dec 31, 202015,003+13.39%
Dec 31, 201913,231+4.13%
Dec 31, 201812,706+2.99%
Dec 31, 201712,337+36.71%
Dec 31, 20169,024+3.17%
Dec 31, 20158,747-12.88%
Dec 31, 201310,040-35.39%
Dec 31, 201115,541+5.97%
Dec 31, 201014,665

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat